Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Galli

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Drug Abuse Reviews|December 14, 2011
Cannabinoid hyperemesis syndromeJonathan A Galli, Ronald Andari Sawaya, Frank K Friedenberg
Respirology (Carlton, Vic.)|March 21, 2017
Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: Tolerability and adverse drug reactionsJonathan A Galli, Aloknath Pandya, Michelle Vega-Olivo, et al.
Respiratory Medicine|April 8, 2014
Home non-invasive ventilation use following acute hypercapnic respiratory failure in COPDJonathan A Galli, Jason S Krahnke, A James Mamary, et al.
Respiratory Medicine|November 17, 2021
Effect of antifibrotic therapy in patients with idiopathic pulmonary fibrosis undergoing lung transplant in the peri and post-operative periodZachariah L Dorey-Stein, William Shapiro, Huaqing Zhao, et al.
Lung|June 18, 2017
Pneumothorax After Transbronchial Biopsy in Pulmonary Fibrosis: Lessons from the Multicenter COMET TrialJonathan A Galli, Nicholas L Panetta, Nathaniel Gaeckle, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 11, 2020
COVID-19 in lung transplant recipientsCatherine N Myers, John Harwood Scott, Gerard J Criner, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 20, 2021
Guiding therapeutic plasma exchange for antibody-mediated rejection treatment in lung transplant recipients - a retrospective studyOlga A Timofeeva, Jason Choe, Mohamed Alsammak, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Drug Abuse Reviews|December 14, 2011
Cannabinoid hyperemesis syndromeJonathan A Galli, Ronald Andari Sawaya, Frank K Friedenberg
Respirology (Carlton, Vic.)|March 21, 2017
Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: Tolerability and adverse drug reactionsJonathan A Galli, Aloknath Pandya, Michelle Vega-Olivo, et al.
Respiratory Medicine|April 8, 2014
Home non-invasive ventilation use following acute hypercapnic respiratory failure in COPDJonathan A Galli, Jason S Krahnke, A James Mamary, et al.
Respiratory Medicine|November 17, 2021
Effect of antifibrotic therapy in patients with idiopathic pulmonary fibrosis undergoing lung transplant in the peri and post-operative periodZachariah L Dorey-Stein, William Shapiro, Huaqing Zhao, et al.
Lung|June 18, 2017
Pneumothorax After Transbronchial Biopsy in Pulmonary Fibrosis: Lessons from the Multicenter COMET TrialJonathan A Galli, Nicholas L Panetta, Nathaniel Gaeckle, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 11, 2020
COVID-19 in lung transplant recipientsCatherine N Myers, John Harwood Scott, Gerard J Criner, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 20, 2021
Guiding therapeutic plasma exchange for antibody-mediated rejection treatment in lung transplant recipients - a retrospective studyOlga A Timofeeva, Jason Choe, Mohamed Alsammak, et al.
Pageof 1